For Use in the United States Only
Order Now

Take control of your patient’s ocular surface. Strengthen patient outcomes.

A reliable, evidence-backed solution for pre-surgical tear film stability and everyday comfort in dry eye patients.
Order Now

Dry eye can present challenges with: biometry accuracy, post-op satisfaction, and everyday patient comfort.

Consider the benefits of using LACRIFILL prior to surgery.

  • Stabilize tear film before cataract or refractive surgery
  • Protect biometry and pre-op planning
  • Reduce post-op complaints
  • Seamlessly fits into your existing workflow

LACRIFILL® Canalicular Gel is the innovative, interventional treatment that optimizes the ocular surface.1,2

A unique cross-linked hyaluronic acid canalicular gel, LACRIFILL fully fills both inferior canaliculi to support biometry precision, tear conservation, and long-lasting dry eye relief for patients.1

One administration. One workflow-friendly step. One consistent way to support the ocular surface—whether your goal is relieving chronic discomfort or optimizing surgical outcomes.

WHY CHOOSE LACRIFILL?

“This technology is disruptive and will change the way we practice ophthalmology and optometry.”

— Eric D. Donnenfeld, MD*

  • Immediate effect with rapid improvement observed as early as seven days2
  • Up to six months of relief per administration2
  • Designed for ocular surface control before surgery and chronic DED
  • Evidence-based confidence, showing significant improvements in tear quantity, TBUT, corneal staining & symptoms2
  • Comfortable, efficient administration. 96% of patients rated treatment “Easy” or “Very Easy”3
“Effective tear conservation in an atraumatic way, in a customizable way. You’ll see the tear meniscus height rise right in front of your eyes, and your patient will feel the benefit right away.”

— Laura Periman, OD*

The Next Evolution in Ocular Surface Control is Here.

Fill out the form below to start your order.

Name(Required)
Ship to Address(Required)
Bill To Address(Required)
  • 1 Lacrifill® Instructions For Use
  • 2 Packer M, et al. J Cataract Refract Surg. 2024 Oct;50(10):1051–1057.
  • 3 Survey data obtained from a February 2025 Nordic Pharma, Inc. patient survey. Survey respondents received compensation for their participation. The authors and MDs and ODs who participated in the survey activity are paid consultants of Nordic Pharma, Inc.
  • *Doctors are paid advisors by Nordic Pharma, Inc.